Maintenance Assessment For Implant Fixed Complete Dentures With Implant Overdentures. A RCT

April 4, 2023 updated by: Nesma Mohamed awaad, Cairo University

Prosthetic Maintenance Assessment For Implant Fixed Complete Dentures With Implant Overdentures. A Randomized Clinical Trial

There are two types of complications in implant prosthesis: biologic and prosthetic . Biologic complications refer to disorders in implant function that disturb the supporting peri-implant tissues resulting in mucositis or periimplantitis in severe conditions, the technical complications refer to subjecting the implant, implant parts and /or the superstructures to a damage ,such as screw loosening ,attachment wear, fracture to part of the prosthesis or some of its teeth. Prosthetic complications after the insertion of the final prosthesis may or may not lead to implant loss but lead to an increase demand for repair and maintenance.

This study aimed to assess whether the telescopic overdenture as a removable prosthesis would necessitate maintaince at frequency similar to that with screw retained hybrid overdenture as a fixed prosthesis.

Study Overview

Status

Completed

Detailed Description

Sample size calculation This power analysis used frequency of implant complications as the primary outcome. Based upon the results of Ragheb NA et al (2021) [15];the proportions of complications were 0.407 and 0.037 in the two groups, respectively. Using alpha (α) level of (5%) and Beta (β) level of (20%) i.e., power = 80%; the minimum estimated sample size was 19 implants per group. Sample size was increased to twenty-two implants per group to compensate for a drop-out rate of 30% after two years. Sample size calculation was performed using G*Power Version 3.1.9.2.

Patients were recruited in the study from the Outpatient Clinic of the Prosthodontics Department, Faculty of Dentistry, Cairo University. All of which were dissatisfied from their previous denture experience and seeking better retention to their mandibular denture. Patients had received verbal and written information about the study procedures and a written informed consent was signed prior to participation.

This study is a randomized clinical trial which was approved by the Ethics Committee of Scientific Research of Cairo University.

In this study , all participants had to install four interforaminal implants to receive either telescopic over-denture or screw retained denture.

Before the prosthetic phase, both groups were randomly assigned according to a computerized random allocation program where data of randomization were entered by the secretary of the department who neither participated in recruitment nor in examination procedures.

Randomization and Allocation concealment was guaranteed as the randomization table was locked with the study coordinator who wasn't involved in any clinical intervention. operator was informed about the treatment modality in a sealed enveloped delivered by the secretary of the department before impression procedures.

Data collection was done by the study coordinator , Blinding of the operator or data collector was not applicable due to the clear difference between the two prostheses but collected data was coded prior to sending to the statistician (blinded statistician).

A preoperative CBCT scan was taken for the participant 's mandibular arch with a scan appliance .The surgical steps were explained for all the participants and an informed consent was signed before surgery.

Intra-foraminal root form tapered threaded dental implants (Neo Biotech Co. Ltd, Seoul, Korea) were installed with 3.5/ 11.5 mm for the anterior and 3.5/10 mm for posterior sites .

Three months later, the surgical stent was used to relocate the implants position for uncovering and the healing abutment was screwed with collar height 5mm to allow for proper gingival healing around the implants prior making the impression.

The impression was made with an open tray splinted implant level impression technique According to randomization, either a telescopic implant supported overdenture or a screw retained denture was fabricated for each case.

During the follow -up period, prosthetic complications were grouped and their frequency was documented according to the type of prosthesis . Both prosthetic and biological aspects were included.

Each complication was documented with stating the frequency of its occurrence, any complication was managed and repaired.

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11351
        • Cairo University
      • Cairo, Egypt, 11351
        • Doaa Mahmoud Elkady
      • Cairo, Egypt, 11351
        • Nesma Mohamed Awaad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • completely edentulous male patients between the age of 50-70 years. patients with HB=bA1C up to 8 with normal blood sugar (79-110) Sufficient bone width (≥ 6 mm) It could be either normally present or achieved by bone plateauing. This will be confirmed by cone beam computed tomographic (CBCT) scans.

Residual bone height ranging from 11-15 mm Patients seeking to install implant and for whom new dentures will be constructed.

Patients, who are dissatisfied with the retention and stability of their technically satisfactory dentures.

Patients providing written informed consents to participate in the trial and this will be done before the scheduled date for implant installation.

Exclusion Criteria:

Any systemic disease that may interfere with dental implants placement and/or Osseointegration as; uncontrolled diabetes, hypertension, osteoporosis and irradiation. Heavy smoker (more than 20 cigarette / day) Patients with parafuctional habits as bruxism and clenching

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental
screw retained prosthesis group this group will received a mandibular screw retained hybrid prosthesis over four inra-foraminal implant
hybrid prosthesis screwed on four mandibular intra-foraminal implants
Other Names:
  • hybrid prosthesis
Active Comparator: active comparator
this group received a mandibular telescopic attached overdenture.
hybrid prosthesis screwed on four mandibular intra-foraminal implants
Other Names:
  • hybrid prosthesis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maintenance
Time Frame: one year
maintenance for complication assed through counting frequency of incidence
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Doaa Elkady phd, Lecturer

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 12, 2019

Primary Completion (Actual)

April 10, 2021

Study Completion (Actual)

November 30, 2022

Study Registration Dates

First Submitted

April 4, 2023

First Submitted That Met QC Criteria

April 4, 2023

First Posted (Actual)

April 18, 2023

Study Record Updates

Last Update Posted (Actual)

April 18, 2023

Last Update Submitted That Met QC Criteria

April 4, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 31922.

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe